HCR 82 -- BIOSIMILAR DRUGS

SPONSOR: Solon

This Concurrent Resolution urges the Department of Social Services and the Office of Administration to conduct studies to examine the potential cost savings of providing enhanced coverage for biosimilar drugs for participants in MO HealthNet and the state employee insurance plan.